Before Bayer (NASDAQOTH: BAYRY) arrived onto the scene, I viewed Monsanto (NYSE: MON) as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio,… Read More: 3 Terrible Reasons to Buy Monsanto »
It only took one solid day for the market to get back to making new highs and nearing new milestones, which goes to show just how much stocks had been meandering for the past several sessions. The Dow is back to within 100 points of 20K after a 0.57% advance on Tuesday to 19912.7. The… Read More: Back in Striking Distance of 20K »
Manufacturer of glass containers, Owens-Illinois, Inc.OI is scheduled to report fourth-quarter 2016 results on Feb 1, after the closing bell. In the last reported quarter, the company reported a year-over-year increase both in earnings and sales. While earnings surpassed the Zacks Consensus Estimate, revenues fell short. Let’s see how things are shaping up prior to… Read More: Owens-Illinois (OI) Q4 Earnings: What's in Store this Time? »